Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Heron Therapeutics Inc., 3 years.
Heron Therapeutics Inc.
Director · EVP, Drug Development
Inhibrx Biosciences Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Inhibrx Biosciences Inc. June 3, 202699.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Inhibrx Biosciences Inc. | Open-market sale | −500 | $105.05 | $52,525 |
| Sep 14, 2026 | Inhibrx Biosciences Inc. | Open-market sale | −500 | $110.26 | $55,130 |
| Sep 11, 2026 | Inhibrx Biosciences Inc. | Open-market sale | −500 | $111.78 | $55,888 |
| Sep 9, 2026 | Inhibrx Biosciences Inc. | Open-market sale | −500 | $115.80 | $57,898 |
| Sep 8, 2026 | Inhibrx Biosciences Inc. | Open-market sale | −500 | $115.14 | $57,570 |
| Aug 28, 2024 | Inhibrx Biosciences Inc. | Open-market purchase | +10,000 | $13.98 | $139,800 |
| Apr 13, 2023 | Heron Therapeutics Inc. | Option exercise | +1,250 | — | — |
| Apr 13, 2023 | Heron Therapeutics Inc. | Option exercise | +4,564 | — | — |
| Apr 13, 2023 | Heron Therapeutics Inc. | Shares withheld for tax | −1,417 | $2.88 | $4,081 |
| Jan 13, 2023 | Heron Therapeutics Inc. | Option exercise | +1,250 | — | — |
| Jan 13, 2023 | Heron Therapeutics Inc. | Option exercise | +4,564 | — | — |
| Jan 13, 2023 | Heron Therapeutics Inc. | Shares withheld for tax | −2,012 | $3.17 | $6,378 |
| Oct 31, 2022 | Heron Therapeutics Inc. | Other | +1,655 | $3.27 | $5,412 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.